Every year the PIs from the Michael Cuccione Childhood Cancer Research Program (MCCCRP) hold a retreat— a day away from the labs and clinic—to look back at our accomplishments and to set goals and objectives for the future. At our retreat we reaffirmed our emphasis on the areas where the MCCCRP has contributed to research for children with cancer, both in B.C. and worldwide. These areas include clinical trials, transplantation and mouse modeling of pediatric cancer diseases.
Improving our clinical research program and adapting it to the changes in the research environment, is the key to our success in enrolling our patients on clinical trials. As a result of our recent evaluation, we are reorganizing our clinical research team structure to expand our program. This is possible through donations focused on clinical research from the Michael Cuccione Foundation. More information will be coming soon. Furthermore, our development of a cell therapies program at the research institute will enable BCCH to give this life saving treatment to children at our hospital, which previously has not been possible.
The major new research initiative involving the whole MCCCRP is the establishment of a novel platform that informs potential clinical approaches and enables directed biology studies of high-risk pediatric cancers.